{"nct_id":"NCT03081234","title":"Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer","status":"WITHDRAWN","status_verified_date":"2018-03","start_date":"2018-03-31","start_date_type":"ESTIMATED","primary_completion_date":"2025-11-17","primary_completion_date_type":"ESTIMATED","completion_date":"2025-11-17","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["NVS"]}